Optimizing pharmacotherapy of generalized anxiety disorder to achieve remission.

@article{Pollack2001OptimizingPO,
  title={Optimizing pharmacotherapy of generalized anxiety disorder to achieve remission.},
  author={Mark H. Pollack},
  journal={The Journal of clinical psychiatry},
  year={2001},
  volume={62 Suppl 19},
  pages={20-5}
}
More than half of patients with generalized anxiety disorder (GAD) have chronic and persistent symptomatology that may warrant ongoing pharmacotherapy. Many of these patients also have significant comorbid mood and anxiety disorders. There is growing consensus among clinicians that the treatment goal for anxiety disorders should be remission, including the minimization of anxiety and depression and resolution of functional impairment. Clinical management strategies for optimizing… CONTINUE READING